Image

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study

Recruiting
18 years and older
Both
Phase N/A

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a genetic condition that affects the brain's blood vessels, leading to cognitive issues like dementia. This study aims to understand how CADASIL progresses and the factors influencing it. The study will include 500 participants with a family history of CADASIL and will last up to five years. Participants will undergo tests, including brain scans (MRI), blood tests, and cognitive assessments, over three in-person visits (initial, 18 months, and 36 months later). They will also have remote check-ins via phone or email.

  • Participants will have three in-person visits over three years.
  • All medications are allowed, but must be documented.
  • Participants will need a "study companion" who knows them well.

Eligible participants must be 18 or older, willing to undergo genetic testing, and have no severe learning disabilities or drug abuse history. If you meet these criteria and want to help advance the understanding of CADASIL, consider joining this study! 🧠💉

Study details
    CADASIL

NCT05677880

University of Wisconsin, Madison

22 June 2024

Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.